According to GlobalData’s medical device pipeline database, 13 Cardiopulmonary Bypass Equipment devices are in various stages of development globally. GlobalData’s report Cardiopulmonary Bypass Equipment provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, six are in active development, while the remaining eight are in an inactive stage of development. There are three products in the early stages of development, and the remaining three are in the late stages of development.
Cardiopulmonary bypass equipment temporarily takes over the function of heart and lungs during an open-heart surgery. Hence, also known as heart-lung machine. The equipment is used to divert the blood returning to the heart, before it returns to the arterial circulation. It works both as a heart i.e., pumps blood and as lungs i.e., supply oxygenated blood to the RBCs. One unit refers to one Cardiopulmonary Bypass Equipment machine.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Cardiopulmonary Bypass Equipment pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Cardiopulmonary Bypass Equipment devices. Overall, most of these Cardiopulmonary Bypass Equipment pipeline devices are being developed by private entities.
Key players involved in the active development of Cardiopulmonary Bypass Equipment include LivaNova, Mayo Clinic, Monash University, Nikkiso, Sree Chitra Tirunal Institute for Medical Sciences & Technology, University of Pittsburgh, VentriFlo, AngioDynamics, Beijing Yuewei Medical Technology and Bicakcilar.
For a complete picture of the developmental pipeline for Cardiopulmonary Bypass Equipment devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.